Park Dental Partners, Inc. Cost of Revenue
Park Dental Partners, Inc. (PARK) reported Cost of Revenue of $56.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-13
- Park Dental Partners, Inc. cost of revenue for the quarter ending 2026-06-30 was $56.70M, a 10.97% increase year-over-year.
- Park Dental Partners, Inc. cost of revenue for the quarter ending 2026-03-31 was $56.31M, a 14.51% increase year-over-year.
- Park Dental Partners, Inc. cost of revenue for the quarter ending 2025-06-30 was $51.09M.
- Park Dental Partners, Inc. cost of revenue for the quarter ending 2025-03-31 was $49.18M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month |
|---|---|---|
| 2026-06-30 | $56.70M 10-Q · filed 2026-08-13 | $113.01M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $56.31M 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $51.09M 10-Q · filed 2026-08-13 | $100.27M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $49.18M 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |